Prevention of hepatitis A virus infection

American Family Physician

Volumn 54, Issue 1, 1996, Pages 107-114

  Moyer, Linda ^a   Warwick, Marion ^b   Mahoney, Francis J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN M ANTIBODY;

ARTICLE; BLOOD CLOTTING DISORDER; CHRONIC LIVER DISEASE; DRUG ABUSE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE PERSONNEL; HEPATITIS A; HEPATITIS A VIRUS; HOMOSEXUALITY; HUMAN; OCCUPATIONAL HAZARD; RISK FACTOR; SEROLOGY; SYMPTOM; TRAVEL; UNITED STATES; VIRUS TRANSMISSION;

HEPATITIS A; HEPATITIS A VACCINES; HEPATOVIRUS; HUMANS; VACCINES, INACTIVATED; VIRAL HEPATITIS VACCINES;

EID: 0030003381     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Hoofnagle JH, Carithers RL Jr, Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop. Hepatology 1995;21:240-52.
2. Hadler SC. Global impact of hepatitis A virus infection: changing patterns. In: Hollinger FB, Lemon SM, Margolis H, eds. Viral hepatitis and liver disease. Baltimore, Md.: Williams & Wilkins, 1991:14-20.
3. Peterson DA, Hurley TR, Hoff JC, Wolfe LG. Effect of chlorine treatment on infectivity of hepatitis A virus. Appl Environ Microbiol 1983;45:223-7.
4. Krugman S, Giles JP. Viral hepatitis. New light on an old disease. JAMA 1970;212:1019-29.
5. Cohen JI, Feinstone S, Purcell RH. Hepatitis A virus infection in a chimpanzee: duration of viremia and detection of virus in saliva and throat swabs. J Infect Dis 1989;160:887-90.
6. Summary of notifiable diseases, United States, 1993. MMWR Morb Mortal Wkly Rep 1993;42:6.
7. Hepatitis surveillance report no. 55. Atlanta: Centers for Disease Control and Prevention, 1994.
8. Hepatitis A among drug abusers. MMWR Morb Mortal Wkly Rep 1988;37:297-300,305.
9. Schade CP, Komorwska D. Continuing outbreak of hepatitis A linked with intravenous drug abuse in Multnomah county. Public Health Rep 1988; 103:452-9.
10. Harkess J, Gildon B, Istre GR. Outbreaks of hepatitis A among illicit drug users, Oklahoma, 1984-87. Am J Public Health 1989;79:463-6.
11. Corey L, Holmes KK. Sexual transmission of hepatitis A in homosexual men: incidence and mechanism. N Engl J Med 1980;302:435-8.
12. Coutinho RA, Albrecht-van Lent P, Lelie N, Nagelkerke N, Kuipers H, Rijsdijk T. Prevalence and incidence of hepatitis A among male homosexuals. Br Med J [Clin Res] 1983;287:1743-5.
13. Hepatitis A in homosexual men - United States, Canada, Australia. MMWR Morb Mortal Wkly Rep 1992;41:155,161-4.
14. Bell BP, Judson FN, Mottram K, et al. The epidemiology of hepatitis A: implications for vaccine use [Abstract]. Interscience Conference. Antimicrob Agents Chemother 1995:326.
15. Clemens R, Safary A, Hepburn A, Roche C, Stanbury WJ, Andre FE. Clinical experience with an inactivated hepatitis A vaccine. J Infect Dis 1995;171(Suppl 1):44-9.
16. Nalin DR, Kuter BJ, Brown L, Patterson C, Calandra GB, Werzberger A, et al. Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview. J Hepatol 1993;18(Suppl 2):51-5.
17. Innis BL, Snitbhan R, Kunasol P, Laorakpongse T, Poopatanakool W, Kozik CA, et al. Protection against hepatitis A by an inactivated vaccine. JAMA 1994;271:1328-34.
18. Werzberger A, Mensch B, Kuter B, Brown L, Lewis J, Sitrin R, et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med 1992;327:453-7.
19. Werzberger A, Kuter B, Shouval D, Mensch B, Brown L, Wiens B, et al. Anatomy of a trial: a historical view of the Monroe inactivated hepatitis A protective efficacy trial. J Hepatol 1993;18(Suppl 2):S46-50.
20. Van Damme P, Thoelen S, Cramm M, DeGroote K, Safary A, Meheus A. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence. J Med Virol 1994;44: 446-51.
21. Bulkow LR, Wainwright RB, McMahon BJ, Middaugh JP, Jenkerson SA, Margolis HS. Secular trends in hepatitis A virus infection among Alaska natives. J Infect Dis 1993;168:1017-20.
22. Shaw FE Jr, Shapiro CN, Welty TK, Dill W, Reddington J, Hadler SC. Hepatitis transmission among the Sioux Indians of South Dakota. Am J Public Health 1990;80:1091-4.
23. Williams R. Prevalence of hepatitis A virus antibody among Navajo school children. Am J Public Health 1986;76:282-3.
24. Pavia AT, Nielsen L, Armington L, Thurman DJ, Tierney E, Nichols CR. A community-wide outbreak of hepatitis A in a religious community: impact of mass administration of immune globulin. Am J Epidemiol 1990;131:1085-93.
25. Sawyer JA, Brown JP, Folke LE, et al. Hepatitis A in a border community. Border Health 1989;5:2-5.
26. Mah MW, Royce RA, Rathouz PJ, Wang JG, White GC 2d, Janco RL, et al. Prevalence of hepatitis A antibodies in hemophiliacs: preliminary results from the Southeastern Delta Hepatitis Study. Vox Sang 1994;67(Suppl 1):21-3.
27. Hepatitis A among persons with hemophilia who received clotting factor concentrate - United States, September-December 1995. MMWR Morb Mortal Wkly Rep 1996;45:29-32.